Wholesome Story vs Fairhaven: Which Capsule Inositol Makes More Sense?

This is one of the most useful capsule comparisons on the site because both products are defensible, but they win for different reasons. Wholesome Story wins on mainstream familiarity and easier public trust. Fairhaven wins when the reader wants a more fertility-specialist feel.

Quick answer

• Pick Wholesome Story for the safest mainstream capsule recommendation.
• Pick Fairhaven for the stronger fertility-leaning capsule recommendation.
• If you want more brand personality, Intimate Rose is the next thing to compare.

Where Wholesome Story wins

Wholesome Story is still easier to recommend broadly because it is the most familiar, easiest-to-justify mainstream capsule answer. The 40:1 myo-inositol to D-chiro combination sits on the same studied ground as the category benchmark, and the main tradeoff is the four-capsule daily serving.

The myo + d-chiro combination behind it has direct cycle-regulation evidence, so the mainstream answer is not just convenient — it sits on studied ground. The main tradeoff remains the four-capsule daily serving.

Where Fairhaven wins

Fairhaven gets stronger when the buyer is comparing products inside a TTC or fertility-support routine and wants something that feels more specialist than mainstream.

The fertility-specialist angle matches a real buyer population — people comparing inside a TTC or fertility-support routine — but it is a brand frame, not a different evidence level: the same low-to-very-low-quality Cochrane base applies to any 40:1 inositol brand. The switch from Wholesome Story to Fairhaven is about intent, not about stronger proof.

How to decide between them

• Choose Wholesome Story when you want the safest, most familiar mainstream capsule recommendation.
• Choose Fairhaven when the routine is fertility-focused and you want a product that feels specialist without switching to powder.

Neither wins on formula strength — both deliver the same 40:1 core in a four-capsule day, and the evidence behind them is the same. The decision is brand fit and buyer intent: mainstream familiarity versus fertility positioning. Whichever you choose, verify the serving delivers the studied dose.

What the evidence says about both

Both products deliver the standard 40:1 myo-inositol to D-chiro-inositol dose in four capsules a day, and the guideline meta-analysis pooled exactly those 40:1 protocols. On the fertility side, the Cochrane review of inositol for subfertile women with PCOS pooled 13 trials with 1,472 women and rated the evidence low to very low quality — the same base for both brands.

That is the practical conclusion: the formula and the evidence are the same, so the comparison is about which brand lane fits the buyer — mainstream capsule familiarity versus a fertility-focused presentation. Neither brand changes the studied dose, the ratio, or the evidence that supports it.

Cost per day: the part most comparisons skip

Here is the math, with prices checked March 10, 2026 — prices vary by retailer and change over time:

• Wholesome Story (30 servings per container): $27.95. 1 serving per day → 30 days per container → about $0.93 per day.
• Fairhaven Health (30 servings per container): $24.99. 1 serving per day → 30 days per container → about $0.83 per day.
• Intimate Rose (30 servings per container): $21.48. 1 serving per day → 30 days per container → about $0.72 per day.
• Optify (30 servings per container): $35.99. 1 serving per day → 30 days per container → about $1.20 per day.

On a per-serving basis, Wholesome Story works out to about $0.93 per day versus Fairhaven Health's $0.83 — a difference of about $0.10 per day.

The honest takeaway: among these, Intimate Rose is the more affordable daily routine on paper, but the right choice still depends on the format and serving burden you will actually stick with. Compare price per day rather than price per bottle.

Final verdict

Wholesome Story stays the safer broad capsule recommendation. Fairhaven becomes stronger when the buyer wants a product that feels more fertility-focused and less generic. That is the cleanest way to separate them.